Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from a seed or nut
Reexamination Certificate
2007-12-11
2007-12-11
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from a seed or nut
C424S758000
Reexamination Certificate
active
11026093
ABSTRACT:
The present invention provides a preferred method for preventing and/or treating a virus infection in aquatic animals, including the steps of: (i) providing a composition including trichoanguin protein; (ii) adding the composition to an aqueous solution including aquatic animals; and (iii) exposing the aquatic animals to the composition; wherein the composition is added in an amount effective to prevent and/or treat the virus infection. Preferably, the trichoanguin protein is provided by a transgenic plant.
REFERENCES:
patent: 5165925 (1992-11-01), Leong
patent: 5401727 (1995-03-01), Rorstad et al.
patent: 6440466 (2002-08-01), Desai et al.
patent: 6705556 (2004-03-01), Laramore
Direkbusarakom et al., Antiviral Activity of Several Thai Traditional Herb Extracts Against Fish Pathogenic Viruses, Fish Pathology, 1996, vol. 34, No. 4, pp. 209-213.
Nielsen et al., Ribosome-Inactivating Proteins: A Plant Perspective, Annual Review of Plant Physiology and Plant Molecular Biology, 2001, vol. 52, pp. 785-816.
Chow et al., Purification, characterization and molecular cloning of trichoanguin, a novel type 1 ribosome-inactivating protein from the seeds ofTrichosanthes anguina, Biochemical Journal, 1999, vol. 338, pp. 211-219.
Chang et al., Dietary B-1,3-glucan effectively improves immunity and survival ofPenaeus monodonchallenged with white spot syndrome virus, Fish and Shellfish Immunology, 2003, vol. 15, pp. 297-310.
Lu et al., Infection competition against grouper nervous necrosis virus by virus-like particles produced inEscherica coli, Journal of General Virology, 2003, vol. 84, pp. 1577-1582.
Yuan et al., Expression of a gene encoding trichosanthin in transgenic rice plants enhances resistance to fungus blast disease, Plant Cell Rep, 2002, vol. 20, pp. 992-998.
Karunasagar et al., Diagnosis, tereatment and prevention of microbial diseases of fish and shellfish, Current Science, 1999, vol. 76, No. 3, pp. 387-399.
Chow, Lu-Ping, et al. Purification, characterization and molecular cloning of trichoanguin, a novel type I ribosome-inactivating protein from the seeds ofTrichosanthes anguina, Biochem. J. (1999) 338, 211-219.
Liu, Wang-Yi and Pu, Zheng, Ribotoxins and Their Applications in Probing the Topographical Structure of Ribosomes, Journal of Natural Toxins, vol. 8, No. 3, (1999).
Gribes, T. Recent Advances in the Uses and Applications of Ribosome-Inactivating Proteins from Plants, Cellular and Molecular Biology, 42 (4), 461-471, (1996).
Maraganore, John M. Purification and Characterization of Trichosanthin—Hormology to the Ricin a Chain and Implications as to Mechanism of Abortifacient Activity, Journal of Biological Chemistry, vol. 262, No. 24, Issue of Aug. 25, 1987, pp. 11628-11633.
Ready, Michael et al. Ricin-like Plant Toxins are Evolutionarily Related to Single-chain Ribosome-inhibiting Proteins from Phytolacca, Journal of Biological Chemistry, vol. 259, No. 24, Issue of Dec. 25, 1984, pp. 15252-15256.
Terenzi, Adelmo et al. Anti-CD30(BER-H2) Immunotoxins Containing the Type-1 Ribosome-Inactivating Proteins Momordin and PAP-S (Pokeweed antiviral Protein from Seeds) Display Powerful Antitumour Activity Against CD30+ Tumour Cells in Vitro and in SCID Mice, British Journal of Haematology, 92, pp. 872-879, (1996).
Bolognesi, Andrea et al. In Vitro Anti-Tumour Activing of Anti-CD80 and Anti-CD86 Immunotoxins Containing Type I Ribosome-Inactivating Proteins, British Journal of Haematology, 110, pp. 351-361 (2000).
Munoz, Raquel et al. Sensitivity of Cancer Cell Lines of the Novel Non-Toxic Type 2 Ribosome-Inactivating Protein Nigrin B, Cancer Letters, 167, pp. 163-169 (2001).
McGrath, Michael S., et al. GLQ223: An Inhibitor of Human Immunodeficiency Virus Replication in Acutely and Chronically Infected Cells of Lymphocyte and Mononuclear Phagocyte Lineage, Proc. Natl. Acad. Sci. USA, vol. 86, pp. 2844-2848, Apr. 1989.
Byers, Vera S., et al. A Phase I/II Study of Trichosanthin Treatment of HIV Disease, AIDS 4, pp. 1189-1196, (1990).
Byers, V.S. et al. A Phase II Study of Effect of Addition of Trichosanthin to Zidovudine in Patients with HIV Disease and Failing Antiretroviral Agents, AIDS Research and Human Retroviruses, vol. 10, No. 4, pp. 413-420, (1994).
Zheng, Y.T. et al. Enhancement of the Anti-Herpectic Effect of Trichosanthin by Acyclovir and Interferon, FEBS Letters, 496, pp. 139-142, (2001).
Gal-On, A. et al. Characterisation of Genetically Modified Cucumber Mosaic Virus Expressing Histidine-Tagged 1a and 2a Proteins, Archives of Virology, 145, pp. 37-50, (2000).
Scholthof, Herman B. et al. Plant Virus Gene Vectors for Transient Expression of Foreign Proteins in Plants, Annu. Rev. of Phytopathol. 34, pp. 299-323, (1996).
Spall, Valerie E. et al. Polyprotein Processing as a Strategy for Gene Expression in RNA Viruses, Seminars in Virology, 8, pp. 15-23, (1997).
Hsiao Hsiung
Su Wei-Chih
Yang Chiung-Hua
Akin Gump Strauss Hauer & Feld & LLP
Campell Bruce R.
Hurt Sharon
ProMd Biotech Co., Ltd.
LandOfFree
Method for preventing and/or treating viral infection in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing and/or treating viral infection in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing and/or treating viral infection in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3829146